|
HS Code |
926378 |
| Product Name | 2,6-Dibromo-3-(trifluoromethyl)pyridine |
| Cas Number | 85118-21-0 |
| Molecular Formula | C6H2Br2F3N |
| Molecular Weight | 319.89 g/mol |
| Appearance | White to light yellow solid |
| Melting Point | 53-56°C |
| Purity | Typically >97% |
| Smiles | C1=C(C(=NC(=C1Br)C(F)(F)F)Br) |
| Inchi | InChI=1S/C6H2Br2F3N/c7-4-2-11-5(8)3(1-4)6(9,10)12 |
| Solubility | Slightly soluble in organic solvents |
| Storage Conditions | Store at room temperature, away from light and moisture |
| Synonyms | 2,6-Dibromo-3-(trifluoromethyl)pyridine |
As an accredited 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g amber glass bottle with a secure screw cap, labeled "2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE," hazard and handling information displayed. |
| Container Loading (20′ FCL) | 20′ FCL typically holds 10–12 MT of 2,6-Dibromo-3-(trifluoromethyl)pyridine, drum-packed, tightly sealed, for safe bulk transport. |
| Shipping | 2,6-Dibromo-3-(trifluoromethyl)pyridine is shipped in tightly sealed, chemical-resistant containers to prevent leakage or moisture ingress. Packaging complies with international regulations for hazardous materials. It is transported in climate-controlled conditions, labeled with appropriate hazard warnings, and handled by trained personnel to ensure safe delivery and compliance with safety and environmental regulations. |
| Storage | 2,6-Dibromo-3-(trifluoromethyl)pyridine should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents. Protect it from moisture and direct sunlight. Store at room temperature and avoid excessive heat. Ensure the storage area is equipped with proper chemical safety protocols and that containers are clearly labeled. |
| Shelf Life | Shelf life of 2,6-Dibromo-3-(trifluoromethyl)pyridine is typically 2-3 years when stored in a cool, dry, tightly sealed container. |
|
Purity 99%: 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE with purity 99% is used in pharmaceutical intermediate synthesis, where high purity ensures consistent yield and product quality. Melting Point 68–72°C: 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE of melting point 68–72°C is used in fine chemical manufacturing, where its controlled thermal behavior allows efficient incorporation in reaction processes. Molecular Weight 338.88 g/mol: 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE with molecular weight 338.88 g/mol is used in agrochemical research, where precise mass enables accurate formulation and dosing. Particle Size <50 μm: 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE of particle size below 50 μm is used in material science studies, where fine particle dispersion improves homogeneous blending in composites. Stability Temperature up to 120°C: 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE with stability temperature up to 120°C is used in catalytic process development, where high thermal stability maintains reactivity under elevated conditions. |
Competitive 2,6-DIBROMO-3-(TRIFLUOROMETHYL)PYRIDINE prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Across the organic synthesis landscape, a few key intermediates make progress possible. 2,6-Dibromo-3-(trifluoromethyl)pyridine stands out among them. As manufacturers, our perspective on this compound centers less on its catalogue entry and more on the ways our partners in agrochemicals, pharmaceuticals, and specialty materials lean on it to solve real-world challenges. The strength and selectivity of this molecule allow research teams to develop compounds that would be out of reach with simpler halogenated pyridines. This difference becomes important as we keep pace with material science and fine chemical development.
Working with 2,6-dibromo-3-(trifluoromethyl)pyridine casts structure-activity relationships in a new light. Manufacturing it at scale created the chance to see how its twin bromine positions open pathways for cross-coupling and substitution reactions unavailable to pyridines bearing less symmetrical substitution. Its trifluoromethyl group, introduced with precision, pushes electron density in a way that brings more nuanced reactivity compared to plain dibromopyridines. Our production teams observe subtle distinctions batch by batch, adjusting process conditions to protect purity—down to minor contaminants that could otherwise stymie a delicate Suzuki, Stille, or Buchwald-Hartwig coupling further down the line.
Scaling up this compound proved more complicated than sketching routes on a blackboard. Trace water content, for example, consistently challenges process engineers because moisture triggers side reactions that generate unwanted mono-bromo or hydrolyzed byproducts. We use controlled-atmosphere synthesis, and our workforce checks each batch not just with standard NMR and GC analysis but with additional mass spectrometry. Customers focused on medicinal chemistry and crop protection count on reliable halogen content and a robust trifluoromethyl presence, since these properties make the difference in yield and downstream safety.
We manufacture 2,6-dibromo-3-(trifluoromethyl)pyridine under several grades. The bulk of our partners rely on material with purity above 98%, but each application shapes what matters most about the product. R&D teams in new agrochemical active ingredient development look for solid, off-white crystals with traceable impurity profiles, especially bromide content. Pharmaceutical clients ask for reliable batch consistency and reproducibility between kilograms and hundreds of kilograms. In our experience, the same product model can vary between brightening agents for liquid chromatography and feedstock for multi-step synthesis of fluorinated drug scaffolds. Nobody’s use case is generic, and lab experience shows small differences in residual solvents or trace halides can slow progress or disable catalytic cycles in more demanding environments.
Every specification choice—melting point range, moisture level, residual solvent cutoff—comes from working with end users who keep us honest about what these numbers mean in practice. Our technical team worked closely with a major European crop protection company whose pilot plant needed exceptionally low levels of tributylamine residue to proceed safely with downstream coupling. The lesson: manufacturing for real-world chemistry calls for a constant loop between process development and end-user feedback, never just a fixed one-sheet spec.
Pyridine chemistry has long been foundational in crop protection, pharmaceuticals, and dye synthesis. The special position of 2,6-dibromo-3-(trifluoromethyl)pyridine comes from its ability to bridge classical halogenated pyridines and the modern world of fluorine chemistry. Unlike simpler mono- or dihalopyridines, this molecule combines a strong electron-withdrawing effect at position 3 from the trifluoromethyl group with the twin reactivity handles created by dual ortho bromines. The combination supports creative and selective functionalizations with palladium- or copper-catalyzed cross-couplings that set up new molecular architectures with fewer steps and higher yields.
Our facility also produces 2,6-dichloro or 3-bromo-5-(trifluoromethyl)pyridine variants. Each displays markedly different reactivity and cost profiles. The dibromotrialkyl group set, as found in 2,6-dibromo-3-(trifluoromethyl)pyridine, gives both the steric accessibility and the electron-poor environment favored by medicinal chemsits working to create lead molecules with improved metabolic stability. Meanwhile, for agricultural discovery chemistry, the compound outperforms standard dichlorinated analogues in promoting regioselective N-arylation or C-alkylation, especially in the presence of difficult-to-control transition metals. These are not footnotes—they define success in process chemistry at scale.
As experienced chemical manufacturers, we know that the real test of a compound begins long after the first lot leaves the reactor. The shipping stability, sensitivity to ambient humidity, and storage robustness all mean more than catalog purity. Our partners emphasize quality not only in numbers but in actual batch traceability—down to glassware or drum type used in logistics.
We realized the compound could hydrolyze slowly in open air, so we seal all finished lots under inert nitrogen and use moisture-barrier packaging before export. Even then, transitional storage yards or minor transit exposures could tip the balance in downstream product consistency. Years ago, we tracked back a failed cross-coupling not to synthesis errors but to micro-exposures during international ocean shipping. Afterward, we altered the packaging regimen, introducing both vacuum-sealed liners and real-time shipment monitoring, improving user yields and reducing troubleshooting time for customers.
The compound’s dense halogenation profile also means it must be handled with environmental and health policies top of mind. Unlike the lighter dichlorinated pyridines, 2,6-dibromo-3-(trifluoromethyl)pyridine could pose more acute hazards in air-sensitive settings and waste treatment after use. We engineered our plant’s air handling and waste systems around this real-world hazard, absorbing halogenated vapors before release and neutralizing residues with proven absorption media.
Transport documentation sometimes lags behind needs for differentiated labeling. We advise our logistics staff on the right hazard and rescue signage for loads at risk of damage or exposure, because real lives—not paperwork—depend on adequate transparency in handling.
Research-driven industries, especially new modes of crop protection and next-generation pharmaceuticals, benefit most from 2,6-dibromo-3-(trifluoromethyl)pyridine. Crop protection specialists lean on the compound as a launching pad for fine-tuned heterocycle assembly, especially when downstream products need to resist UV degradation or enzymatic breakdown in the field. Our close relationships with formulation chemists tell us these trifluoromethylated scaffolds perform better during long sunlight or soil exposure.
Teams working to develop herbicide or fungicide leads stress that the dibrominated pattern in this compound delivers a wider palette for positional selectivity during ligand construction. They tell us this reduces dead-end syntheses and enables better high-throughput screening for activity and persistence.
Pharmaceutical innovation depends on nuanced differences between halogenated heterocycles. Medicinal chemists trust 2,6-dibromo-3-(trifluoromethyl)pyridine for greater scaffold diversification, using its dual leaving groups and trifluoromethyl group to anchor new molecular probes, candidates for CNS and anti-infective research, and preclinical imaging agents. Following detailed conversations with research units, we adjusted our cleaning protocols and changed batch scheduling to limit cross-contamination with closely related pyridines. This decision, based on hands-on feedback, led to better reliability during downstream NMR and HPLC monitoring, especially where trace overlap would have forced costly rework.
This compound does more than just anchor an intermediate step. In our experience, it allows project flows that might otherwise be stopped by side reactions, poor purification, or scale bottlenecks. Chemical route designers use our detailed impurity data not for liability shielding, but to speed up time-to-results in real-world research projects. Every lot we produce reflects direct partnerships with users asking: what could derail product quality, and what do they see under their conditions?
Supplying 2,6-dibromo-3-(trifluoromethyl)pyridine demands more than batch production and QA signoff. We keep constant watch on upstream supply of bromine and fluorinated building blocks. Tightening regulation on halogen supply in key mining geographies affects cost and planning timelines for labs in Europe, the Americas, and Asia. Clients planning clinical or registration-scale trials can double their annual requirements without warning, and our plant recalibrates production to cover these spikes. We learned from the 2020-2023 period that advance stockpiling and regular customer consultation ease downstream disruption far more effectively than just-in-time manufacture.
Freight offers other lessons. Into some countries, air restrictions on halogenated goods lengthen lead times. Regular dialogues with customs officials and transport partners help prevent bottlenecks. We implemented dual-path logistics, covering both sea and regulated air, to guarantee faster response for urgent orders, after years of lost opportunity traced to slow-moving or mishandled shipments.
Storage remains a common pitfall. On-site, keeping product away from acids, oxidants, and direct sunlight avoids degradation. Our clients shared reports that ambient warehouse humidity levels—rarely tracked outside the plant—can affect what users receive. So, we engineered our own humidity-tracking shipment containers, with data delivered at delivery. Such approaches stem from long conversations with both laboratory directors and warehouse managers who together spot trends that are not obvious inside a manufacturing plant but critical at the user end.
For our team, the search for quality improvement never ends once an industrial route delivers the minimum 98% purity. Each time a research partner signals an issue with processability, unexpected batch variance, or even odor during handling, our technical group tracks the root cause all the way back to upstream production methods. Several years ago, a pattern of lower coupling yields in a synthetic batch led us to revisit the purification of the trifluoromethylated intermediate. Implementing incremental distillation steps, combined with solvent-recovery optimization, improved final product integrity and cut down on extraneous peaks in downstream chromatography.
We also see the environmental toll of halogenated pyridines. Waste stream management must match the complexity of the chemistry itself. Through solvent recovery, multistep halide scrubbing, and final carbon capture on incinerator tail gases, we reduce the environmental burden of pyridine manufacture. These investments grew from fielding user concerns about waste permits and local discharge compliance—not theoretical best practice, but practical feedback from buyers seeking to maintain their own compliance.
Improvement shows in packaging as well. Early on, we used basic fiberboard containers with polymer liners for product shipment. After receiving user concerns about breakage and sorption, we shifted to steel drums with multilayered barrier bags, preventing micro-contamination and exposure during long transit or adverse loading conditions. Shipping teams now report fewer claims and reduced on-arrival complaints, and feedback from customer logistics managers validates continuous packaging innovation.
As a manufacturer with long-standing relationships in custom and catalogue pyridine chemistry, we see room for shared improvement across specialty halogenated intermediates. Joint projects with leading research institutes and multinational users show that small changes in supply documentation and product handling protocols result in smoother pilot plant scale-ups.
From labs in Tokyo developing next-generation anti-infectives to European crop protection researchers working to cut solvent and reagent use, the compound’s flexibility supports new approaches. Several partners consulted with us to derive new biotransformation routes or shortened synthesis steps for their proprietary scaffolds using our material as a backbone. Each successful modification, from reaction temperature tuning to solvent adaptation, resulted from a two-way dialogue built on transparency.
We have also shifted internal reference methods away from boilerplate characterization towards user-centric diagnostics. Instead of relying solely on standard GC or HPLC, we now include platform-specific screening, including compatibility with user conditions, to provide meaningful assurances about how each lot performs under stress. Years of feedback showed that an analytic approach tailored to the intended transformation delivers more value than static “pass” or “fail” metrics.
Comparisons with other pyridinic intermediates often overlook the subtleties that differentiate 2,6-dibromo-3-(trifluoromethyl)pyridine. Products with fewer or different halogen substitutions may seem interchangeable, but our direct experience proves otherwise. The dual bromo groups not only provide two reactive sites for further functionalization, but also facilitate positions for controlled sequential substitution. Their effect combined with the trifluoromethyl substituent imparts greater chemical flexibility than counterparts lacking these features.
Cost sometimes enters the conversation, with some users considering less halogenated or fluorinated options as a workaround for budget constraints. Through detailed side-by-side testing and proof-of-concept synthesis, teams discovered that these “easy saves” resulted in lower yields, more purification steps, and lost time. The effort required to rework unsuccessful reactions and purify intermediates erased most initial savings. The high atom economy, fewer side reactions, and more predictable workups with 2,6-dibromo-3-(trifluoromethyl)pyridine often delivered total project savings that only became clear at full scale.
The trifluoromethyl group at position three creates meaningful contrasts. Not only does it influence physical properties, such as increasing lipophilicity for pharmaceutical leads or supporting UV resistance for agrochemical actives, but it steers regioselectivity in both metal-catalyzed and base-induced reactions. No other halogenated pyridine in our catalog lines up quite so well with the requirements faced by synthetic chemists determined to explore boundary-pushing reactivity.
For some uses, dichlorinated or monobrominated analogues suffice, yet where selectivity, product stability, and high-value transformations are at stake, users circle back to this molecule. Experienced process chemists have shared that, after iterative comparative studies, only the dibromo-trifluoromethyl construction satisfied both yield and regulatory profile for new submissions in crop protection or preclinical review.
Our experience manufacturing 2,6-dibromo-3-(trifluoromethyl)pyridine goes beyond compliance and spec sheets. Lasting partnership with users and a willingness to adjust manufacturing practices in response to detailed process feedback set apart what we do. The compound has earned its place by repeatedly demonstrating that subtle control over structure and purity pays off—from research bench through field trial and into industrial-scale programs.
Clients turn to us at the concept stage to review potential synthesis challenges and continue the conversation down the line, as new process requirements emerge. The resulting circle of improvement draws on lived manufacturing experience, field-tested product handling, and trust built with every shipment delivered on-spec and on time.
2,6-Dibromo-3-(trifluoromethyl)pyridine stands as a reliable cornerstone for discovery and development across advanced chemical industries. For each kilo that leaves our facility, we track not just purity and yield, but the ongoing improvements and collaborative exchanges that define leadership in specialty chemical manufacturing. The difference lies in attention to the details that matter each step of the way—from raw material sourcing to the critical final transformation in a customer’s hands.